“Jay is an incredibly knowledgeable and capable leader, who brings over 25 years of experience in healthcare policy, reimbursement, payer operations, health economics and marketing at leading global medical device companies and two government agencies, CMS and HHS,” said
“I would also like to thank Maggie for her years of hard work and leadership,” Mr. Mattys continued. “Her strategic guidance has been a driving force behind the development of our in-house reimbursement operations and payer relations team and the establishment of our expertise in this area, which has become a core area of marketplace differentiation for Tactile Medical. We appreciate her continued contributions to our team in this important new role.”
Prior to joining Tactile Medical, Mr. Stracke was Senior Director of Global Clinical and Health Economic Marketing at Smiths Medical, a leading global manufacturer of specialty medical devices focused on the medication delivery, vital care and vascular access market segments. At Smiths Medical, he established and led a new division to develop and support value-based marketing and sales strategies, as well as a new post-market value-based research team to improve scientific evidence and customer awareness of the company’s brand, products and patient value. Mr. Stracke has also held positions as Director of Government Affairs and Market Access for
Prior to his career in the medical device industry, Mr. Stracke was the Deputy Director of the Centers for
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Tactile Medical’s Mission is to help people suffering from chronic diseases live better and care for themselves at home. The Company’s unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.
Legal Notice Regarding Forward-Looking Statements:
This release contains forward-looking statements. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “confident,” “outlook” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties outside of the Company’s control that can make such statements untrue, including, but not limited to, the adequacy of the Company’s liquidity to pursue its complete business objectives; the Company’s ability to obtain reimbursement from third party payers for its products; loss or retirement of key executives; adverse economic conditions or intense competition; loss of a key supplier; entry of new competitors and products; adverse federal, state and local government regulation; technological obsolescence of the Company’s products; technical problems with the Company’s research and products; the Company’s ability to expand its business through strategic acquisitions; the Company’s ability to integrate acquisitions and related businesses; price increases for supplies and components; the effects of current and future U.S. and foreign trade policy and tariff actions; or the inability to carry out research, development and commercialization plans. In addition, other factors that could cause actual results to differ materially are discussed in the Company’s filings with the
Investor Inquiries:Mike Piccinino , CFA Managing DirectorWestwicke Partners 443-213-0500 [email protected]
Source: Tactile Systems Technology, Inc.